Natural Alternatives Q4 Loss Widens Y/Y on Margin Pressure

NAII posts y/y sales growth in Q4'26, but a $10.4M impairment charge and factory underutilization weigh on profitability.

Zacks Investment Research • Sep 29, 2026

Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results

CARLSBAD, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced today a net loss of $13.5 million, or ($2.23) per diluted share, on net sales of $34.5 million for the fourth quarter of fiscal year 2026 compared to a net loss of $7.2 million, or ($1.20) per diluted share, in the fourth quarter of the prior fiscal year. Our net loss for the fourth quarter of fiscal 2026 includes a non-recurring non-cash charge of $10.4 million related to the impairment of our Carlsbad, CA manufacturing facility due to its underutilization. Excluding this charge, our net loss for the fourth quarter of fiscal 2026 would have been $3.1 million, or ($0.52) per diluted share.

GlobeNewsWire • Sep 28, 2026

3 Microcaps for Your Watchlist

NHTC, HCWC, and NAII sell into the growing nutrition and wellness space.

Zacks Investment Research • Aug 6, 2026

Top 3 Risk Off Stocks That May Rocket Higher In Q3

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Benzinga • Jul 15, 2026

Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure

NAII's Q3 sales rise 23% y/y, but a wider loss and margin pressure offset gains from stronger contract manufacturing demand.

Zacks Investment Research • Jun 1, 2026

Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results

CARLSBAD, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $4.3 million, or $0.72 per diluted share, on net sales of $35.5 million for the third quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the third quarter of the prior fiscal year.

GlobeNewsWire • May 19, 2026

Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase

NAII posts higher Q2 sales but wider losses, and trims its outlook for fiscal 2026 amid softer customer forecasts and launch delays.

Zacks Investment Research • Feb 18, 2026

Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results

CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.6 million, or $0.42 per diluted share, on net sales of $34.8 million for the second quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the second quarter of the prior fiscal year.

GlobeNewsWire • Feb 13, 2026

Niche Focus & Regulation Shape the Future of Healthcare Firms

CPIX, NAII and ICCC lean into specialization, compliance and targeted growth to thrive in the niche healthcare markets.

Zacks Investment Research • Jan 15, 2026

Natural Alternatives International, Inc. Announces 2026 Q1 Results

CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $0.3 million, or $0.05 per diluted share, on net sales of $37.7 million for the first quarter of fiscal year 2026 compared to a net loss of $2.0 million, or $0.33 per diluted share, in the first quarter of the prior fiscal year.

GlobeNewsWire • Nov 12, 2025